Mavyret on AARP Medicare Rx Preferred from UHC (S5820-038)
glecaprevir and pibrentasvir
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 140 per 28 days.
$3,701.09
Patient pays / month, after deductible
$4,162.34
Patient pays / month, before the $615.00 deductible
$11,103.28
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
MAVYRET 20/50 mg Pellet at a preferred retail pharmacy, from the plan's negotiated price of $14,804.37 for a month. Other covered strengths are listed below.
Prior authRequired on all 2 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 2 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| MAVYRET 20/50 mg Pellet | 5 | $3,701.09 | PA · 140 per 28 days |
| MAVYRET 40/100 mg Tablet, Film Coated | 5 | $4,383.30 | PA · 84 per 28 days |
Other Hepatitis C drugs on this plan
Verify with the plan before prescribing or filling. Member services: (888)867-5575. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5820-038